top of page

The first non-invasive neurostimulation solution

for obstructive sleep apnea

Somnair Treats Obstructive Sleep Apnea at the

Root Cause

nerve.png

Neurostimulation Therapy

Picture3.png

Non-Invasive

Picture2.png

Deployed at Home

Abell-logo.png
spark-logo-transparent.png
FUEL-Image-Web.png
Johns_Hopkins_Carey_Business_School's_Logo.png
Heartland challenge_edited.jpg
DPP Startup 302 Logo_JPG.webp
CBID-logo-web.webp
hopstart.png

Latest Buzz

Stay in the loop with our latest milestones and exciting news!
Discover what we've been up to and be part of our journey towards innovation.

25_SXSW_Pitch-Finalist_web.png

Somnair Selected as Finalist for 2025 SXSW PITCH

Screenshot 2024-04-25 at 12.05.04 AM.png

2nd Place at Rice Business Plan Competition

image_edited_edited.jpg

1st Place at ASU Innovation Open

Subscribe to our newsletter • Don’t miss out!

Thanks for subscribing!

Get in Touch

The Somnair device is currently in the pre-clinical development stage and is not yet commercially available. It is on the pathway to clinical studies, and any information provided is subject to change as research progresses.

bottom of page